Observational studyMedicine2017

Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.

Shinri Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.